
Health Care Issues | |
Taking Our Pills |
While pharmaceutical companies seem to be holding the line on drug cost-increases,
Americans are taking more pills, industry observers say. Health insurers and managed-care companies have long known the benefits
of early treatment in holding down costs. But they see the current rise
in drug usage as negatively affecting profits. Observers say HMOs failed to anticipate drug-makers' success in marketing
new therapies. In fact, patients often tell their doctors now what particular
drug therapies they want. Industry experts predict that the benefits to patients of earlier and
improved therapies will eventually translate into improved bottom-lines
for insurers and HMOs. But it may take awhile. Source: Amy Barrett, "Drug Costs Just Won't Go Down Easy,"
Business Week, November 24, 1997. |
Home | Support Us | All Issues | Social Security | Debate Central | Contact Us
Dallas Headquarters: 12770 Coit Rd., Suite 800 - Dallas, TX 75251-1339 - 972/386-6272 - Fax 972/386-0924
Washington Office: 601 Pennsylvania Avenue NW, Suite 900 South Building, Washington, DC 20004 - 202/220-3082 - Fax 202/220-3096
© 2001 NCPA